CATS Tonometer IOP Reduction Latanoprost Verses Timolol

Status Recruiting

Clinical Trial Summary

Topical Prostaglandin Analog vs Betablocker - Corneal Biomechanical Evaluation using CATS Tonometer Prism

Clinical Trial Description

This clinical trial is a prospective, controlled, study and will be performed at one clinical investigative site in Tucson Arizona1. The purpose of this study is to determine if the device, CATS tonometer prism, measures intraocular pressure significantly differently than the current standard of care tonometer prism (Goldmann) before and after institution of topical prostaglandin analogs (PGA) for glaucoma treatment. Fifty percent of patients will be randomly placed on topical beta blockers as a control. The difference PGAs and beta blockers would be a measurement of the amount of corneal biomechanical changes made due to the PGA controlled for the effect of IOP lowering by the beta -blocker group. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04178863
Study type	Interventional
Source	Intuor Technologies, Inc.
Contact
Status	Recruiting
Phase	Phase 4
Start date	July 1, 2018
Completion date	December 30, 2019

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03338088` - Evaluation of Adherence to Clinical Treatment of Glaucoma	N/A
Not yet recruiting	`NCT04007276` - The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients	Phase 4
Recruiting	`NCT03220490` - Efficacy and Necessity of Time Interval Between Instillation of Two Glaucoma Eye Drops	N/A
Completed	`NCT05319470` - Ocular Surface Disease and IOP Monitoring With Travoprost Without Conservatives
Completed	`NCT03323164` - Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study	Phase 4
Enrolling by invitation	`NCT04381611` - INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register
Not yet recruiting	`NCT03595865` - Efficacy of Tafluprost as an Adjunct to Medical Therapy for Residual Glaucoma After Trabeculectomy	N/A
Recruiting	`NCT06369077` - How Much Does Reduced Dosing of Latanoprost and Dorzolamide-timolol Affect Pressure?	Phase 4